Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso

Background: Colorectal cancer (CRC) is an heterogeneous disease. Three carcinogenic pathways determine its molecular profile: microsatellite instability (MSI), chromosomal instability (CIN) and CpG island methylator phenotype (CIMP). Based on the new molecular classification, four consensus CRC mole...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wielandt,Ana María, Villarroel,Cynthia, Hurtado,Claudia, Simian,Daniela, Zamorano,Diego, Martínez,Maripaz, Castro,Magdalena, Vial,María Teresa, Kronberg,Udo, López-Kostner,Francisco
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2017
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000400001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872017000400001
record_format dspace
spelling oai:scielo:S0034-988720170004000012017-07-18Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consensoWielandt,Ana MaríaVillarroel,CynthiaHurtado,ClaudiaSimian,DanielaZamorano,DiegoMartínez,MaripazCastro,MagdalenaVial,María TeresaKronberg,UdoLópez-Kostner,Francisco Carcinogenesis Chromosomal Instability Colorectal Neoplasms CpG Island Microsatellite Instability Background: Colorectal cancer (CRC) is an heterogeneous disease. Three carcinogenic pathways determine its molecular profile: microsatellite instability (MSI), chromosomal instability (CIN) and CpG island methylator phenotype (CIMP). Based on the new molecular classification, four consensus CRC molecular subtypes (CMS) are established, which are related to clinical, pathological and biological characteristics of the tumor. Aim: To classify Chilean patients with sporadic CRC according to the new consensus molecular subtypes of carcinogenic pathways. Material and Methods: Prospective analytical study of 53 patients with a mean age of 70 years (55% males) with CRC, operated at a private clinic, without neoadjuvant treatment. From normal and tumor tissue DNA of each patient, CIN, MSI and CIMP were analyzed. Combining these variables, tumors were classified as CMS1/MSI-immune, CMS2/canonical, CMS3/metabolic and CMS4/mesenchymal. Results: CMS1 tumors (19%) were located in the right colon, were in early stages, had MMR complex deficiencies and 67% had an activating mutation of the BRAF oncogene. CMS2 tumors (31%) were located in the left colon, had moderate differentiation, absence of vascular invasion, lymphatic and mucin. CMS3 tumors (29%) were also left-sided, with absence of vascular and lymphatic invasion, and 29% had an activating mutation of the KRAS oncogene. CMS4 tumors (21%) showed advanced stages and presence of metastases. Conclusions: This new molecular classification contributes to understanding the heterogeneity of tumors. It is possible to differentiate molecular subgroups of a single pathological diagnosis of adenocarcinoma, opening the door to personalized medicine.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.145 n.4 20172017-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000400001es10.4067/S0034-98872017000400001
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Carcinogenesis
Chromosomal Instability
Colorectal Neoplasms
CpG Island
Microsatellite Instability
spellingShingle Carcinogenesis
Chromosomal Instability
Colorectal Neoplasms
CpG Island
Microsatellite Instability
Wielandt,Ana María
Villarroel,Cynthia
Hurtado,Claudia
Simian,Daniela
Zamorano,Diego
Martínez,Maripaz
Castro,Magdalena
Vial,María Teresa
Kronberg,Udo
López-Kostner,Francisco
Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso
description Background: Colorectal cancer (CRC) is an heterogeneous disease. Three carcinogenic pathways determine its molecular profile: microsatellite instability (MSI), chromosomal instability (CIN) and CpG island methylator phenotype (CIMP). Based on the new molecular classification, four consensus CRC molecular subtypes (CMS) are established, which are related to clinical, pathological and biological characteristics of the tumor. Aim: To classify Chilean patients with sporadic CRC according to the new consensus molecular subtypes of carcinogenic pathways. Material and Methods: Prospective analytical study of 53 patients with a mean age of 70 years (55% males) with CRC, operated at a private clinic, without neoadjuvant treatment. From normal and tumor tissue DNA of each patient, CIN, MSI and CIMP were analyzed. Combining these variables, tumors were classified as CMS1/MSI-immune, CMS2/canonical, CMS3/metabolic and CMS4/mesenchymal. Results: CMS1 tumors (19%) were located in the right colon, were in early stages, had MMR complex deficiencies and 67% had an activating mutation of the BRAF oncogene. CMS2 tumors (31%) were located in the left colon, had moderate differentiation, absence of vascular invasion, lymphatic and mucin. CMS3 tumors (29%) were also left-sided, with absence of vascular and lymphatic invasion, and 29% had an activating mutation of the KRAS oncogene. CMS4 tumors (21%) showed advanced stages and presence of metastases. Conclusions: This new molecular classification contributes to understanding the heterogeneity of tumors. It is possible to differentiate molecular subgroups of a single pathological diagnosis of adenocarcinoma, opening the door to personalized medicine.
author Wielandt,Ana María
Villarroel,Cynthia
Hurtado,Claudia
Simian,Daniela
Zamorano,Diego
Martínez,Maripaz
Castro,Magdalena
Vial,María Teresa
Kronberg,Udo
López-Kostner,Francisco
author_facet Wielandt,Ana María
Villarroel,Cynthia
Hurtado,Claudia
Simian,Daniela
Zamorano,Diego
Martínez,Maripaz
Castro,Magdalena
Vial,María Teresa
Kronberg,Udo
López-Kostner,Francisco
author_sort Wielandt,Ana María
title Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso
title_short Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso
title_full Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso
title_fullStr Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso
title_full_unstemmed Caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso
title_sort caracterización de pacientes con cáncer colorrectal esporádico basado en la nueva subclasificación molecular de consenso
publisher Sociedad Médica de Santiago
publishDate 2017
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000400001
work_keys_str_mv AT wielandtanamaria caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT villarroelcynthia caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT hurtadoclaudia caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT simiandaniela caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT zamoranodiego caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT martinezmaripaz caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT castromagdalena caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT vialmariateresa caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT kronbergudo caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
AT lopezkostnerfrancisco caracterizaciondepacientesconcancercolorrectalesporadicobasadoenlanuevasubclasificacionmoleculardeconsenso
_version_ 1718436937759457280